TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,726,000 | -44.4% | 141,997 | -35.2% | 0.55% | -30.4% |
| Q2 2021 | $8,503,000 | -31.3% | 219,197 | -14.7% | 0.79% | -31.3% |
| Q1 2021 | $12,382,000 | -7.3% | 256,897 | 0.0% | 1.16% | +13.4% |
| Q4 2020 | $13,364,000 | +94.4% | 256,897 | 0.0% | 1.02% | +85.3% |
| Q3 2020 | $6,875,000 | -48.8% | 256,897 | -62.8% | 0.55% | -55.8% |
| Q2 2020 | $13,438,000 | +61.0% | 689,821 | -18.7% | 1.24% | +28.8% |
| Q1 2020 | $8,346,000 | -60.6% | 848,221 | -55.5% | 0.97% | -36.7% |
| Q4 2019 | $21,173,000 | +61.5% | 1,907,492 | -18.3% | 1.53% | +41.0% |
| Q3 2019 | $13,107,000 | -55.6% | 2,334,196 | -31.6% | 1.08% | -53.3% |
| Q2 2019 | $29,537,000 | -8.2% | 3,414,668 | -14.7% | 2.32% | -9.0% |
| Q1 2019 | $32,188,000 | +107.1% | 4,003,481 | +5.6% | 2.55% | +96.6% |
| Q4 2018 | $15,545,000 | +26.8% | 3,791,531 | +73.1% | 1.30% | +82.8% |
| Q3 2018 | $12,264,000 | -57.4% | 2,190,085 | 0.0% | 0.71% | -54.6% |
| Q2 2018 | $28,800,000 | -14.6% | 2,190,085 | -7.7% | 1.56% | -23.7% |
| Q1 2018 | $33,710,000 | -6.4% | 2,373,920 | -45.9% | 2.04% | -14.0% |
| Q4 2017 | $36,011,000 | -42.6% | 4,391,634 | -17.1% | 2.38% | -36.7% |
| Q3 2017 | $62,746,000 | +34.4% | 5,295,044 | +14.0% | 3.76% | +41.0% |
| Q2 2017 | $46,685,000 | -13.3% | 4,645,265 | +0.5% | 2.66% | -13.3% |
| Q1 2017 | $53,855,000 | +135.3% | 4,622,749 | -6.1% | 3.07% | +93.1% |
| Q4 2016 | $22,883,000 | -43.2% | 4,921,059 | -5.4% | 1.59% | -41.4% |
| Q3 2016 | $40,284,000 | +27.7% | 5,204,618 | 0.0% | 2.71% | +33.2% |
| Q2 2016 | $31,540,000 | +10.7% | 5,204,618 | +55.6% | 2.04% | +3.4% |
| Q1 2016 | $28,503,000 | -22.1% | 3,345,469 | +9.0% | 1.97% | +62.8% |
| Q4 2015 | $36,605,000 | +18.9% | 3,068,315 | +0.5% | 1.21% | -42.4% |
| Q3 2015 | $30,783,000 | +20.7% | 3,053,916 | +98.6% | 2.10% | +160.2% |
| Q2 2015 | $25,508,000 | -19.7% | 1,537,529 | -25.1% | 0.81% | -62.0% |
| Q1 2015 | $31,762,000 | +12.6% | 2,051,821 | +15.2% | 2.12% | +19.5% |
| Q4 2014 | $28,204,000 | -26.5% | 1,780,538 | -50.5% | 1.78% | -32.1% |
| Q3 2014 | $38,355,000 | +60.4% | 3,594,621 | +41.1% | 2.61% | +55.3% |
| Q2 2014 | $23,916,000 | +36.1% | 2,547,000 | 0.0% | 1.68% | +43.4% |
| Q1 2014 | $17,574,000 | +173.6% | 2,547,000 | +54.6% | 1.17% | +161.5% |
| Q4 2013 | $6,423,000 | -15.0% | 1,647,000 | +9.8% | 0.45% | -17.0% |
| Q3 2013 | $7,560,000 | – | 1,500,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |